Seeking Alpha

Arena (ARNA -0.7%) rewards the VP of its regulatory affairs, Craig Audet, for his role in the...

Arena (ARNA -0.7%) rewards the VP of its regulatory affairs, Craig Audet, for his role in the company receiving FDA approval for weight-loss drug Belviq by promoting him to Senior VP, Operations and Head of Global Regulatory Affairs. Audet's new role will also include investor relations and alliance management. (PR)
Comments (3)
  • Leadership and ability is worth more than gold.
    5 Jul 2012, 10:24 AM Reply Like
  • I looked up his bio and it is outstanding.
    5 Jul 2012, 11:58 AM Reply Like
  • "Perfect Choice" !!!!!!
    5 Jul 2012, 03:13 PM Reply Like
DJIA (DIA) S&P 500 (SPY)